CYNTHIA SCHUETZ BOYD SMITH: Open Payments
NPI 1043541337 · NEWTON, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 29 payments from 13 companies in 2025. Trend: 2023 $428 · 2024 $565 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $116 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $106 |
| Stryker Corporation | 1 | $53 |
| Olympus America Inc. | 1 | $28 |
| Merck Sharp & Dohme LLC | 1 | $25 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| Sagent Pharmaceuticals | 1 | $21 |
| PROGENICS PHARMACEUTICALS, INC. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: ERLEADA, Nubeqa, XIFAXAN, NEPTUNE, iTIND System, KEYTRUDA, PLUVICTO, Glydo.
Industry payments across MS — which companies pay providers there.
